Cargando…

Special Issue “Antibody Engineering for Cancer Immunotherapy”

Detalles Bibliográficos
Autores principales: Crescioli, Silvia, White, Ann L., Karagiannis, Sophia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036255/
https://www.ncbi.nlm.nih.gov/pubmed/35466282
http://dx.doi.org/10.3390/antib11020029
_version_ 1784693482921656320
author Crescioli, Silvia
White, Ann L.
Karagiannis, Sophia N.
author_facet Crescioli, Silvia
White, Ann L.
Karagiannis, Sophia N.
author_sort Crescioli, Silvia
collection PubMed
description
format Online
Article
Text
id pubmed-9036255
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90362552022-04-26 Special Issue “Antibody Engineering for Cancer Immunotherapy” Crescioli, Silvia White, Ann L. Karagiannis, Sophia N. Antibodies (Basel) Editorial MDPI 2022-04-15 /pmc/articles/PMC9036255/ /pubmed/35466282 http://dx.doi.org/10.3390/antib11020029 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Crescioli, Silvia
White, Ann L.
Karagiannis, Sophia N.
Special Issue “Antibody Engineering for Cancer Immunotherapy”
title Special Issue “Antibody Engineering for Cancer Immunotherapy”
title_full Special Issue “Antibody Engineering for Cancer Immunotherapy”
title_fullStr Special Issue “Antibody Engineering for Cancer Immunotherapy”
title_full_unstemmed Special Issue “Antibody Engineering for Cancer Immunotherapy”
title_short Special Issue “Antibody Engineering for Cancer Immunotherapy”
title_sort special issue “antibody engineering for cancer immunotherapy”
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036255/
https://www.ncbi.nlm.nih.gov/pubmed/35466282
http://dx.doi.org/10.3390/antib11020029
work_keys_str_mv AT cresciolisilvia specialissueantibodyengineeringforcancerimmunotherapy
AT whiteannl specialissueantibodyengineeringforcancerimmunotherapy
AT karagiannissophian specialissueantibodyengineeringforcancerimmunotherapy